cdmo.directory
← Compare landing

Glatt vs UPM Pharmaceuticals

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/glatt/upm-inc

CategoryGlattUPM Pharmaceuticals
Listed sitecdmocdmo
SummaryGlatt Pharmaceutical Services is a CDMO specializing in complex oral solid dosage forms, multiparticulate systems (pellets, micropellets, granules), and advanced drug delivery solutions including controlled release, solubility enhancement, and taste masking from early development through commercial manufacturing.Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.
Services
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Technology Transfer
  • Oral Solid Dosage Manufacturing
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Process Development
  • Technology Transfer
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Controlled Substance Manufacturing
  • HPAPI Manufacturing (High-Potency)
Modalities
  • Small Molecule
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Binzen, Baden-Württemberg, Germany
  • Weimar Technology Center, Weimar, Thuringia, Germany
  • Ramsey, Ramsey, New Jersey, USA
  • Broughton Astley, Broughton Astley, Leicestershire, United Kingdom
  • Headquarters & Manufacturing Facility, Bristol, Tennessee, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.